πŸ‡ΊπŸ‡Έ FDA
Patent

US 11753398

Therapeutic compounds

granted A61PA61P25/00A61P3/04

Quick answer

US patent 11753398 (Therapeutic compounds) held by C4X Discovery Limited expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
C4X Discovery Limited
Grant date
Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P25/00, A61P3/04